Patents Assigned to Novitium Pharma LLC
  • Hydrochlorothiazide compositions
    Patent number: 11878022
    Abstract: Disclosed herein is a powder for oral suspension and a reconstituted product thereof comprising highly pure hydrochlorothiazide, which is useful for treating hypertension and edema.
    Type: Grant
    Filed: November 7, 2022
    Date of Patent: January 23, 2024
    Assignee: Novitium Pharma LLC
    Inventors: Muthusamy Shanmugam, Subramaniam Arunkumar
  • TABLET FOR ORAL SUSPENSION
    Publication number: 20230398078
    Abstract: Disclosed herein is a tablet for oral suspension comprising carglumic acid and its use.
    Type: Application
    Filed: March 29, 2023
    Publication date: December 14, 2023
    Applicant: Novitium Pharma LLC
    Inventors: Muthusamy SHANMUGAM, Shivanand Premanand PUTHLI
  • Tablet for oral suspension
    Patent number: 11628143
    Abstract: Disclosed herein is a tablet for oral suspension comprising carglumic acid and its use.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: April 18, 2023
    Assignee: Novitium Pharma LLC
    Inventors: Muthusamy Shanmugam, Shivanand Premanand Puthli
  • HYDROCHLOROTHIAZIDE COMPOSITIONS
    Publication number: 20230111273
    Abstract: Disclosed herein is a powder for oral suspension and a reconstituted product thereof comprising highly pure hydrochlorothiazide, which is useful for treating hypertension and edema.
    Type: Application
    Filed: November 7, 2022
    Publication date: April 13, 2023
    Applicant: Novitium Pharma LLC
    Inventors: Muthusamy SHANMUGAM, Subramaniam ARUNKUMAR
  • HYDROCHLOROTHIAZIDE COMPOSITIONS
    Publication number: 20220184094
    Abstract: Disclosed herein is a powder for oral suspension and a reconstituted product therein comprising highly pure hydrochlorothiazide, which is useful for treating hypertension and edema.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 16, 2022
    Applicant: Novitium Pharma LLC
    Inventors: Muthusamy SHANMUGAM, Shivappa SHASHIKUMAR, Subramaniam ARUNKUMAR
  • STABLE ORAL LIQUID COMPOSITION OF TERAZOSIN
    Publication number: 20220047508
    Abstract: The present invention relates to novel stable oral liquid composition of Terazosin and its pharmaceutically acceptable salt which is useful for treating symptomatic benign prostatic hyperplasia (BPH) and hypertension.
    Type: Application
    Filed: August 27, 2021
    Publication date: February 17, 2022
    Applicant: Novitium Pharma LLC
    Inventors: Muthusamy SHANMUGAM, Palanisamy SIVAKUMAR
  • Stable oral liquid composition of terazosin
    Patent number: 11224572
    Abstract: The present invention relates to novel stable oral liquid composition of Terazosin and its pharmaceutically acceptable salt which is useful for treating symptomatic benign prostatic hyperplasia (BPH) and hypertension.
    Type: Grant
    Filed: February 1, 2021
    Date of Patent: January 18, 2022
    Assignee: Novitium Pharma LLC
    Inventors: Muthusamy Shanmugam, Palanisamy Sivakumar